Pacira Pharmaceuticals Inc (PCRX)

43.70
0.30 0.69
NASDAQ : Health Care
Prev Close 43.40
Open 43.45
Day Low/High 42.95 / 44.05
52 Wk Low/High 31.08 / 80.25
Volume 439.68K
Avg Volume 1.07M
Exchange NASDAQ
Shares Outstanding 37.40M
Market Cap 1.62B
EPS 0.10
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Short Interest Jumps 15.6% For PCRX

Short Interest Jumps 15.6% For PCRX

The most recent short interest data has been released for the 01/31/2017 settlement date, which shows a 836,945 share increase in total short interest for Pacira Pharmaceuticals Inc. , to 6,219,273, an increase of 15.55% since 01/13/2017.

Biotech Premarket Movers: Pacira, Clearside Biomedical and Organovo

Biotech Premarket Movers: Pacira, Clearside Biomedical and Organovo

Pacira Pharmaceuticals, Clearside Biomedical and Organovo Holdings are among the premarket biotech movers on Wednesday.

DePuy Synthes Announces Exclusive Co-Promotional Agreement With Pacira Pharmaceuticals, Inc.

DePuy Synthes Announces Exclusive Co-Promotional Agreement With Pacira Pharmaceuticals, Inc.

EXPAREL® Provides Orthopaedic Patients Long-Lasting, Non-Opioid Postsurgical Pain Control at the Surgical Site

Bullish and Bearish Reversals in the Market

Bullish and Bearish Reversals in the Market

These companies show signs of a change of direction.

Pacira Pharmaceuticals Reports Preliminary 2016 Revenues Of $276.4 Million

Pacira Pharmaceuticals Reports Preliminary 2016 Revenues Of $276.4 Million

EXPAREL net product sales driven by soft tissue and orthopedic procedures

Choppiness Usually Ends With Some Sort of Decline

Typically, the best way to get sentiment to turn is to take the indexes down.

Interesting PCRX Put And Call Options For August 2017

Interesting PCRX Put And Call Options For August 2017

Investors in Pacira Pharmaceuticals Inc. saw new options begin trading this week, for the August 2017 expiration.

Pacira Pharmaceuticals And GeneAlign Announce Partnership To Develop Low-Opioid Pain Management Protocols For Postsurgical Patients At High Risk Of Addiction

Pacira Pharmaceuticals And GeneAlign Announce Partnership To Develop Low-Opioid Pain Management Protocols For Postsurgical Patients At High Risk Of Addiction

Collaboration will leverage genetic testing to identify patients predisposed to developing addiction following opioid exposure

Interesting PCRX Put And Call Options For January 2017

Interesting PCRX Put And Call Options For January 2017

Investors in Pacira Pharmaceuticals Inc. saw new options become available this week, for the January 2017 expiration.

American College Of Surgeons Launches Education Program On Opioids And Surgery: Use, Abuse, And Alternatives

American College Of Surgeons Launches Education Program On Opioids And Surgery: Use, Abuse, And Alternatives

Pacira grant will allow for the development and distribution of resources to educate patients and surgeons on opioid use in surgical care

Analysts' Actions -- Quintiles, Royal Caribbean, Western Digital and More

Analysts' Actions -- Quintiles, Royal Caribbean, Western Digital and More

Here are Thursday's top research calls, including an upgrade for Western Digital and downgrades for Quintiles and Royal Caribbean.

First Week of December 16th Options Trading For Pacira Pharmaceuticals (PCRX)

First Week of December 16th Options Trading For Pacira Pharmaceuticals (PCRX)

Investors in Pacira Pharmaceuticals Inc. saw new options begin trading this week, for the December 16th expiration.

Pacira Pharmaceuticals Continues To Build Out Robust Commercial Leadership Team

Pacira Pharmaceuticals Continues To Build Out Robust Commercial Leadership Team

Company Appoints Thomas Sluby as Vice President, Sales and Matthew Lehmann as Vice President, Marketing

Pacira Pharmaceuticals Announces Official Launch Of EXPAREL To The Oral Surgeon Community To Treat Pain Following Oral And Maxillofacial Procedures

Pacira Pharmaceuticals Announces Official Launch Of EXPAREL To The Oral Surgeon Community To Treat Pain Following Oral And Maxillofacial Procedures

New research presented at AAOMS 2016 shows EXPAREL is safe and effective for pain relief following removal of wisdom teeth

Perilous Reversal Stock: Pacira Pharmaceuticals (PCRX)

Perilous Reversal Stock: Pacira Pharmaceuticals (PCRX)

Trade-Ideas LLC identified Pacira Pharmaceuticals (PCRX) as a "perilous reversal" (up big yesterday but down big today) candidate

Trade-Ideas: Pacira Pharmaceuticals (PCRX) Is Today's

Trade-Ideas: Pacira Pharmaceuticals (PCRX) Is Today's "Barbarian At The Gate" Stock

Trade-Ideas LLC identified Pacira Pharmaceuticals (PCRX) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate

Pacira Pharmaceuticals (PCRX) Flagged As Strong On High Volume

Pacira Pharmaceuticals (PCRX) Flagged As Strong On High Volume

Trade-Ideas LLC identified Pacira Pharmaceuticals (PCRX) as a strong on high relative volume candidate